Creatine is POSSIBLY INEFFECTIVE in
the treatment of amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease)[2].
McGeer EG, McGeer PL, Pharmacological approaches to
the treatment of amyotrophic lateral sclerosis, BioDrugs 19:31 - 37, 2005 709.
Not exact matches
A new review examines the potential
of antioxidant approaches for the
treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease,
amyotrophic lateral sclerosis, and multiple
sclerosis.
The same
treatment killed many other types
of neurons, including both the spinal motor neurons that die in
amyotrophic lateral sclerosis and the human dopaminergic neurons whose mysterious loss is the cause
of Parkinson's disease.
In the medium term, the approach should contribute to the development
of treatments for paralytic diseases such as infantile spinal muscular amyotrophy or
amyotrophic lateral sclerosis.
S. Stefanie, H Bettina, Nilges M, Schroeder S, Hoelich A, Keletzl H, Spooren W, Ostrowitzki S, Hanania T, Sendtner M, Metzger F. Functional improvement in mouse models
of familial
amyotrophic lateral sclerosis by PEGylated insulin - like growth factor I
treatment depends on disease severity.
This consortium
of researchers, clinicians, and patients, has «systematically investigated and graded» evidence for over 35 «alternative»
treatments for
Amyotrophic Lateral Sclerosis (ALS, aka Lou Gehrig's disease), a fatal disease that destroys the nerve cells that control voluntary muscle movement.
BM - MNCs are another cell population under extensive evaluation in clinical trials for
treatment of cardiovascular diseases and for peripheral vascular disease, including critical limb ischemia, as well as for
amyotrophic lateral sclerosis (ALS), stroke, obstructive pulmonary disease and more.
Aetna considers navigated transcranial magnetic stimulation experimental and investigational for motor function mapping and / or
treatment planning
of neurological diseases / disorders (e.g.,
amyotrophic lateral sclerosis, epilepsy, and resection
of brain tumors) because its value and effectiveness has not been established.
The creative use
of neuroimaging and other techniques is helping McLean scientists better diagnose and develop new
treatments for a range
of conditions including substance use disorders, neuropsychiatric conditions such as schizophrenia, major depression, post-traumatic stress disorder (PTSD), obsessive compulsive disorder (OCD), and neurodegenerative diseases such as Parkinson's disease and
amyotrophic lateral sclerosis (ALS).
Merit Cudkowicz's research and clinical activities are dedicated to the study and
treatment of patients with neurodegenerative disorders, in particular
amyotrophic lateral sclerosis (ALS) and Huntington's disease (HD).
& Cambridge, MA About Blog ProMIS ™ Neurosciences, Inc., is a development stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective
treatment of neurodegenerative diseases, in particular Alzheimer's disease (AD) and
amyotrophic lateral sclerosis (ALS).
The biggest thing is making sure you can qualify for life insurance with SBLI, so lets cover (in general) what SBLI will and won't insure: SBLI Underwriting Uninsurable medical scenarios with SBLI: • Aids / HIV + status • ALS (
Amyotrophic Lateral Sclerosis) • Alzheimer's disease or dementia or significant cognitive impairments related to functionality • Cancer diagnosis within last 2 years • Chronic pain
treatment, severe, receiving disability, narcotic use • Cirrhosis
of the Liver • Congestive heart Failure • COPD / Emphysema or chronic bronchitis - Severe or with current nicotine use • Cystic Fibrosis • Defibrillator use • Depression, severe, recurrent or with multiple in - patient hospitalization history • Diabetes with co-morbidities that include significant cardiac disease, or impairment
of renal function or mobility • Heart / Cardiac Disease - multiple vessels diagnosed within 2 years or any past history with current nicotine use • Muscular Dystrophy • Multiple
Sclerosis, if symptoms progressing • Organ Transplants, in most scenarios • Quadriplegia • Pulmonary hypertension • Renal failure, Renal insufficiency - severe • Stroke within 1 year • Suicide attempt within 5 years • Surgical repair
of heart valves, aneurysms, intracranial tumors, major organs within six months, including gastric bypass Uninsurable non-medical scenarios: • Marijuana use, 4 or more times weekly • Substance abuse / misuse within last 5 years • Criminal activity - any history within the last 10 years • DUI, more than 2 or under age 25 if within 1 year • Unemployed (other than homemakers or retired) with minimal household income or dependent on SSI / disability benefits • Bankruptcy filing within 2 years • Liens / Judgements - outstanding activity that exceeds $ 50K
& Cambridge, MA About Blog ProMIS ™ Neurosciences, Inc., is a development stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective
treatment of neurodegenerative diseases, in particular Alzheimer's disease (AD) and
amyotrophic lateral sclerosis (ALS).
& Cambridge, MA About Blog ProMIS ™ Neurosciences, Inc., is a development stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective
treatment of neurodegenerative diseases, in particular Alzheimer's disease (AD) and
amyotrophic lateral sclerosis (ALS).